MétaCan
Menu
← Back to cohort
Record W1597122917 · doi:10.1158/1538-7445.am2014-909

Abstract 909: Defining molecular and laboratory predictive biomarkers of response to cisplatin-based neoadjuvant chemotherapy (NC) in muscle-invasive bladder cancer (MIBC) - preliminary results and future plans

2014· article· en· W1597122917 on OpenAlexaff
Raya Leibowitz‐Amit, Jo-An Seah, Raanan Berger, Srikala S. Sridhar

Bibliographic record

VenueCancer Research · 2014
Typearticle
Languageen
FieldMedicine
TopicBladder and Urothelial Cancer Treatments
Canadian institutionsPrincess Margaret Cancer Centre
Fundersnot available
KeywordsMedicineBladder cancerCystectomyCisplatinOncologyInternal medicineChemotherapyCancerCohortGemcitabine

Abstract

fetched live from OpenAlex

Abstract Background: MIBC is common, yet there has been little progress in its research, with no new therapeutic agents approved in years. The optimal therapeutic modalities and treatment sequence are not entirely well-defined. Cisplatin-based NC prior to definitive radical cystectomy (RC) increases overall survival (OS), yet is only active in a proportion of patients (pts). A pathological complete response (pCR) at RC is associated with improved OS, but there are currently no molecular biomarkers predicting which pts are likely to achieve pCR, and thus treatment decisions are currently based solely on clinical parameters. Methods: Since micro-RNAs (miRNAs) are known to be key-players in cancer, we chose to study the differences in miRNA expression patterns between 7 pts who achieved pCR and 9 pts who did not respond (‘responders’ and ‘non-responders’, respectively), using commercial micro-arrays (Agilent ®) and quantitative RT-PCR. In a different cohort, we performed a retrospective chart review of 29 pts with MIBC receiving NC to find associations between clinical, biochemical or radiological characteristics and pCR. As the peripheral blood neutrophil-to-lymphocyte ratio (NLR) is thought to non-specifically correlate with systemic inflammatory burden, we analyzed its levels before and during NC as well as prior to RC. Results: The trend of change in NLR was significantly different between responders and non-responders (p=0.039), the former exhibiting a sustained decrease in NLR throughout chemotherapy up until RC, and the latter exhibiting a transient decrease in NLR by mid-NC, followed by an increase to above baseline. One miRNA was significantly lower in responders than in non-responders (q value=0.048, corrected for multiple comparisons), and five miRNAs with the identical seed sequence (thus potentially targeting the same mRNAs) were also all lower in responders, one with borderline significance (q value=0.1, corrected). Conclusions: These findings suggest that chemo-sensitivity of MIBC is determined by both inherent molecular characteristics as well as the immune/inflammatory system, and raises the question whether the response to NC could be enhanced by decreasing the systemic inflammatory burden. We will corroborate these results in larger pts cohorts and search for potential targets of these miRNAs. We also plan to initiate a prospective multi-center clinical trial in which both intra-tumoral and circulating miRNAs, as well as micro-environment/systemic inflammatory markers, will be monitored and assessed in order to establish predictive factors for pCR with NC. Citation Format: Raya Leibowitz-Amit, Jo-An Seah, Raanan Berger, Srikala S. Sridhar. Defining molecular and laboratory predictive biomarkers of response to cisplatin-based neoadjuvant chemotherapy (NC) in muscle-invasive bladder cancer (MIBC) - preliminary results and future plans. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 909. doi:10.1158/1538-7445.AM2014-909

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.347
Teacher spread0.325 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueCancer Research→Same topicBladder and Urothelial Cancer Treatments→French-language works237,207→